MERCADOLIBRE INC (MELI) Fundamental Analysis & Valuation

NASDAQ:MELI • US58733R1023

Current stock price

1855.83 USD
+33.7 (+1.85%)
At close:
1862 USD
+6.17 (+0.33%)
After Hours:

This MELI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. MELI Profitability Analysis

1.1 Basic Checks

  • In the past year MELI was profitable.
  • In the past year MELI had a positive cash flow from operations.
  • Each year in the past 5 years MELI has been profitable.
  • MELI had a positive operating cash flow in each of the past 5 years.
MELI Yearly Net Income VS EBIT VS OCF VS FCFMELI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • MELI has a better Return On Assets (4.68%) than 66.67% of its industry peers.
  • MELI's Return On Equity of 29.59% is amongst the best of the industry. MELI outperforms 93.33% of its industry peers.
  • MELI has a better Return On Invested Capital (16.97%) than 90.00% of its industry peers.
  • MELI had an Average Return On Invested Capital over the past 3 years of 21.88%. This is significantly above the industry average of 8.75%.
  • The 3 year average ROIC (21.88%) for MELI is well above the current ROIC(16.97%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROIC 16.97%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
MELI Yearly ROA, ROE, ROICMELI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

1.3 Margins

  • With a decent Profit Margin value of 6.91%, MELI is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • MELI's Profit Margin has improved in the last couple of years.
  • MELI has a Operating Margin of 11.08%. This is in the better half of the industry: MELI outperforms 80.00% of its industry peers.
  • MELI's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 44.50%, MELI is in line with its industry, outperforming 56.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MELI has remained more or less at the same level.
Industry RankSector Rank
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
MELI Yearly Profit, Operating, Gross MarginsMELI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MELI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELI is creating value.
  • The number of shares outstanding for MELI remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for MELI has been increased compared to 5 years ago.
  • MELI has a better debt/assets ratio than last year.
MELI Yearly Shares OutstandingMELI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MELI Yearly Total Debt VS Total AssetsMELI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • MELI has an Altman-Z score of 2.80. This is not the best score and indicates that MELI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of MELI (2.80) is comparable to the rest of the industry.
  • The Debt to FCF ratio of MELI is 0.85, which is an excellent value as it means it would take MELI, only 0.85 years of fcf income to pay off all of its debts.
  • MELI has a Debt to FCF ratio of 0.85. This is amongst the best in the industry. MELI outperforms 83.33% of its industry peers.
  • MELI has a Debt/Equity ratio of 0.68. This is a neutral value indicating MELI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.68, MELI is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
  • Even though the debt/equity ratio score it not favorable for MELI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Altman-Z 2.8
ROIC/WACC1.83
WACC9.27%
MELI Yearly LT Debt VS Equity VS FCFMELI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • MELI has a Current Ratio of 1.17. This is a normal value and indicates that MELI is financially healthy and should not expect problems in meeting its short term obligations.
  • MELI has a worse Current ratio (1.17) than 73.33% of its industry peers.
  • A Quick Ratio of 1.15 indicates that MELI should not have too much problems paying its short term obligations.
  • MELI has a Quick ratio of 1.15. This is comparable to the rest of the industry: MELI outperforms 46.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15
MELI Yearly Current Assets VS Current LiabilitesMELI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MELI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.51% over the past year.
  • The Earnings Per Share has been growing by 60.44% on average over the past years. This is a very strong growth
  • Looking at the last year, MELI shows a very strong growth in Revenue. The Revenue has grown by 39.06%.
  • Measured over the past years, MELI shows a very strong growth in Revenue. The Revenue has been growing by 48.70% on average per year.
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%

3.2 Future

  • Based on estimates for the next years, MELI will show a very strong growth in Earnings Per Share. The EPS will grow by 35.40% on average per year.
  • Based on estimates for the next years, MELI will show a quite strong growth in Revenue. The Revenue will grow by 19.27% on average per year.
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y35.4%
Revenue Next Year34.11%
Revenue Next 2Y29.11%
Revenue Next 3Y25.17%
Revenue Next 5Y19.27%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MELI Yearly Revenue VS EstimatesMELI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
MELI Yearly EPS VS EstimatesMELI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 100 200 300

More info and screens

Find the best growth stocksShow best growing peers

5

4. MELI Valuation Analysis

4.1 Price/Earnings Ratio

  • MELI is valuated quite expensively with a Price/Earnings ratio of 47.10.
  • MELI's Price/Earnings is on the same level as the industry average.
  • MELI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.87.
  • Based on the Price/Forward Earnings ratio of 34.80, the valuation of MELI can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MELI indicates a slightly more expensive valuation: MELI is more expensive than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, MELI is valued at the same level.
Industry RankSector Rank
PE 47.1
Fwd PE 34.8
MELI Price Earnings VS Forward Price EarningsMELI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MELI.
  • Based on the Price/Free Cash Flow ratio, MELI is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.73
EV/EBITDA 23.05
MELI Per share dataMELI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

  • MELI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of MELI may justify a higher PE ratio.
  • A more expensive valuation may be justified as MELI's earnings are expected to grow with 37.07% in the coming years.
PEG (NY)1.33
PEG (5Y)N/A
EPS Next 2Y36.63%
EPS Next 3Y37.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MELI Dividend Analysis

5.1 Amount

  • MELI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MELI Fundamentals: All Metrics, Ratios and Statistics

MERCADOLIBRE INC

NASDAQ:MELI (4/17/2026, 8:00:00 PM)

After market: 1862 +6.17 (+0.33%)

1855.83

+33.7 (+1.85%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners82.77%
Inst Owner Change0.01%
Ins Owners0.26%
Ins Owner Change0%
Market Cap94.09B
Revenue(TTM)28.89B
Net Income(TTM)2.00B
Analysts83.87
Price Target2598.08 (40%)
Short Float %2.21%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.17%
Min EPS beat(2)-12.64%
Max EPS beat(2)-5.7%
EPS beat(4)1
Avg EPS beat(4)-4.66%
Min EPS beat(4)-15.3%
Max EPS beat(4)14.99%
EPS beat(8)4
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)3.94%
EPS beat(16)10
Avg EPS beat(16)6.86%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.61%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.88%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)5.59%
Revenue beat(8)6
Avg Revenue beat(8)3%
Revenue beat(12)10
Avg Revenue beat(12)2.83%
Revenue beat(16)13
Avg Revenue beat(16)3.26%
PT rev (1m)-8.98%
PT rev (3m)-9.17%
EPS NQ rev (1m)-8.71%
EPS NQ rev (3m)-19.87%
EPS NY rev (1m)-8.86%
EPS NY rev (3m)-13.56%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)5.57%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)4.47%
Valuation
Industry RankSector Rank
PE 47.1
Fwd PE 34.8
P/S 3.26
P/FCF 8.73
P/OCF 7.77
P/B 13.94
P/tB 14.36
EV/EBITDA 23.05
EPS(TTM)39.4
EY2.12%
EPS(NY)53.33
Fwd EY2.87%
FCF(TTM)212.49
FCFY11.45%
OCF(TTM)238.97
OCFY12.88%
SpS569.88
BVpS133.1
TBVpS129.23
PEG (NY)1.33
PEG (5Y)N/A
Graham Number343.497 (-81.49%)
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROCE 22.81%
ROIC 16.97%
ROICexc 30.8%
ROICexgc 31.6%
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
FCFM 37.29%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
ROICexc(3y)229.5%
ROICexc(5y)162.58%
ROICexgc(3y)538.3%
ROICexgc(5y)354.16%
ROCE(3y)29.4%
ROCE(5y)23.88%
ROICexgc growth 3Y-33.3%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.99%
ROICexc growth 5YN/A
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Debt/EBITDA 1.14
Cap/Depr 164.18%
Cap/Sales 4.65%
Interest Coverage 5.24
Cash Conversion 301.47%
Profit Quality 539.46%
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 2.8
F-Score5
WACC9.27%
ROIC/WACC1.83
Cap/Depr(3y)133.57%
Cap/Depr(5y)162.49%
Cap/Sales(3y)4.05%
Cap/Sales(5y)5%
Profit Quality(3y)459.33%
Profit Quality(5y)464.07%
High Growth Momentum
Growth
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y35.4%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%
Revenue Next Year34.11%
Revenue Next 2Y29.11%
Revenue Next 3Y25.17%
Revenue Next 5Y19.27%
EBIT growth 1Y21.66%
EBIT growth 3Y44.14%
EBIT growth 5Y90.47%
EBIT Next Year54.93%
EBIT Next 3Y39.18%
EBIT Next 5Y30.45%
FCF growth 1Y52.64%
FCF growth 3Y63.06%
FCF growth 5Y63.03%
OCF growth 1Y53.02%
OCF growth 3Y60.33%
OCF growth 5Y59.26%

MERCADOLIBRE INC / MELI Fundamental Analysis FAQ

What is the fundamental rating for MELI stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELI.


What is the valuation status for MELI stock?

ChartMill assigns a valuation rating of 5 / 10 to MERCADOLIBRE INC (MELI). This can be considered as Fairly Valued.


How profitable is MERCADOLIBRE INC (MELI) stock?

MERCADOLIBRE INC (MELI) has a profitability rating of 8 / 10.


How financially healthy is MERCADOLIBRE INC?

The financial health rating of MERCADOLIBRE INC (MELI) is 6 / 10.


What is the earnings growth outlook for MERCADOLIBRE INC?

The Earnings per Share (EPS) of MERCADOLIBRE INC (MELI) is expected to grow by 35.36% in the next year.